Skip to main content
Erschienen in: European Journal of Trauma and Emergency Surgery 6/2016

27.11.2015 | Original Article

Efficacy of glutathione mesotherapy in burns: an experimental study

verfasst von: A. Buz, T. Görgülü, A. Olgun, E. Kargi

Erschienen in: European Journal of Trauma and Emergency Surgery | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

Thermal burns are the leading cause of trauma worldwide. Currently, no consensus on optimal treatment of deep partial-thickness (second-degree) burns has emerged, as reflected by the wide variability in available wound-care materials. The relative efficacies of products used for treatment of partial-thickness thermal burns remain unclear. Mesotherapy features intradermal administration of various agents, depending on burn location. In the present experimental study, we explored the efficacy of mesotherapy used to treat partial-thickness thermal burns in 50 male Wistar rats divided into five groups of equal number. No procedure was performed after infliction of thermal burns in control group (Group 1). Mesotherapy was applied with physiological saline in sham group (Group 2), glutathione, taurine, and l-carnitine were separately applied in Group 3, Group 4, and Group 5, respectively.

Materials and methods

Mesotherapeutic agents were injected intradermally into the reticular layer of the dermis using the point technique. The first course of mesotherapy was given within the first 2 h after infliction of thermal burns, and therapy was continued to day 10. On day 22, unhealed thermal burn areas were measured prior to sacrifice, and biopsies covering the total areas of burns were performed to allow of pathological evaluation.

Results

Group 3 (the glutathione group) showed the best extent of healing, followed by Group 4 (the taurine group) and Group 5 (the l-carnitine group). The healed thermal burn areas in these groups were significantly greater than those in the control and sham groups (P = 0.001). All of healing, acute and chronic inflammation, the amount of granulation tissue, the level of fibroblast maturation, the amount of collagen, the extent of re-epithelization and neovascularization, and ulcer depth were scored upon pathological examination of tissue cross-sections. The best outcomes were evident in the glutathione group, with statistical significance. Although wound healing in the l-carnitine and taurine groups was better than in the control and sham groups, the differences were not statistically significant.

Conclusion

Thus, glutathione mesotherapy was effective when used to treat partial-thickness thermal burns and may be a useful treatment option for various human burns.
Literatur
1.
Zurück zum Zitat Kuyumcu M, Şen H, Özkan S. Anesthesia in Burn Injury Patients. TAF Prev Med Bull. 2011;10(3):351–60.CrossRef Kuyumcu M, Şen H, Özkan S. Anesthesia in Burn Injury Patients. TAF Prev Med Bull. 2011;10(3):351–60.CrossRef
2.
Zurück zum Zitat Griffs RW. Management of multiple casualties with burns. BMJ. 1985;291:917–8.CrossRef Griffs RW. Management of multiple casualties with burns. BMJ. 1985;291:917–8.CrossRef
3.
Zurück zum Zitat Zor F, Ersöz N, Külahçı Y, Kapı E, Bozkurt M. Gold standards for primary care of burn management. Dicle Med J. 2009;36(3):219–25. Zor F, Ersöz N, Külahçı Y, Kapı E, Bozkurt M. Gold standards for primary care of burn management. Dicle Med J. 2009;36(3):219–25.
4.
Zurück zum Zitat Kahn SA, Patel JH, Lentz CW, et al. Firefighter Burn injures: predictable patterns influenced by Turnout Gear. J Burn Care Res. 2012;33(1):152–6.CrossRefPubMed Kahn SA, Patel JH, Lentz CW, et al. Firefighter Burn injures: predictable patterns influenced by Turnout Gear. J Burn Care Res. 2012;33(1):152–6.CrossRefPubMed
5.
Zurück zum Zitat Schwarze H, Küntsher M, Uhling C, Hierlemann H, Prantl L, Ottomann C, Hartmann B. Suprathel a new skin substitue, in the management of partial-thickness burn wounds. Ann Plast Surg. 2008;60:181–5.CrossRefPubMed Schwarze H, Küntsher M, Uhling C, Hierlemann H, Prantl L, Ottomann C, Hartmann B. Suprathel a new skin substitue, in the management of partial-thickness burn wounds. Ann Plast Surg. 2008;60:181–5.CrossRefPubMed
6.
Zurück zum Zitat Atiyeh BS, Gun SW, Hayek SN. State of the art in burn treatment. World J Surg. 2005;29:131–48.CrossRefPubMed Atiyeh BS, Gun SW, Hayek SN. State of the art in burn treatment. World J Surg. 2005;29:131–48.CrossRefPubMed
7.
Zurück zum Zitat Haik J, Ashkenazy O, Sinai S, et al. Burn care standards in israel: lack of concensus. Burns. 2005;31:845–9.CrossRefPubMed Haik J, Ashkenazy O, Sinai S, et al. Burn care standards in israel: lack of concensus. Burns. 2005;31:845–9.CrossRefPubMed
8.
Zurück zum Zitat Caruso DM, Foster KN, Hermans MHE, Rick C. Aquacel Ag in the management of partial-thickness burns: results of a clinical trial. J Burn Care Rehabil. 2004;25:89–97.CrossRefPubMed Caruso DM, Foster KN, Hermans MHE, Rick C. Aquacel Ag in the management of partial-thickness burns: results of a clinical trial. J Burn Care Rehabil. 2004;25:89–97.CrossRefPubMed
9.
Zurück zum Zitat Lefbaschoff G, Steher D. Mesotherapy in the treatment of cellulite. In: Goldman MP, Balci PA, Leibaschoff G, Hexel D, Angelini F, editors. Cellulite pathophysichology and treatment. New York: Taylor & Francis Group; 2006. p. 263–86. Lefbaschoff G, Steher D. Mesotherapy in the treatment of cellulite. In: Goldman MP, Balci PA, Leibaschoff G, Hexel D, Angelini F, editors. Cellulite pathophysichology and treatment. New York: Taylor & Francis Group; 2006. p. 263–86.
10.
11.
Zurück zum Zitat Caruso MK, Roberts AT, Bissoon L, et al. An evolution of mesotherapy solutions for inducing lipolysis and trating cellulite. J Plast Reconstruct Aesthet Surg. 2008;61(11):1321–4.CrossRef Caruso MK, Roberts AT, Bissoon L, et al. An evolution of mesotherapy solutions for inducing lipolysis and trating cellulite. J Plast Reconstruct Aesthet Surg. 2008;61(11):1321–4.CrossRef
12.
Zurück zum Zitat Atiyeh Bishara S, İbrahim Amir E, Dibo Saad A. Cosmetik mesotherapy: between Scientitic Cuidince. Science, fiction and lucrative busines Aesth plast Surg. 2008;32:842–9.CrossRef Atiyeh Bishara S, İbrahim Amir E, Dibo Saad A. Cosmetik mesotherapy: between Scientitic Cuidince. Science, fiction and lucrative busines Aesth plast Surg. 2008;32:842–9.CrossRef
13.
Zurück zum Zitat Larizzo M, De Padava MP, Tosti A. Mesotherapi in sken rejuvenation. In: Tosti A, De Padova MP, editors. Atlas of mesotherapy in skin rejuvenation. London: Informa UK Ltd; 2007. p. 1–8. Larizzo M, De Padava MP, Tosti A. Mesotherapi in sken rejuvenation. In: Tosti A, De Padova MP, editors. Atlas of mesotherapy in skin rejuvenation. London: Informa UK Ltd; 2007. p. 1–8.
14.
Zurück zum Zitat Mysore V. Mesotherapy in Management of Hairloss—Is it of Any Use? . Int J Tricholoji. 2010;2(4):45–6.CrossRef Mysore V. Mesotherapy in Management of Hairloss—Is it of Any Use? . Int J Tricholoji. 2010;2(4):45–6.CrossRef
15.
Zurück zum Zitat Vedamurthy M. Mesotherapy. Indian J. Dermatol Venerol Lepral. 2007;73(1):60–2.CrossRef Vedamurthy M. Mesotherapy. Indian J. Dermatol Venerol Lepral. 2007;73(1):60–2.CrossRef
16.
Zurück zum Zitat Farriol M, Rosello J, Schwarz S. Body surface area in sprague—Dowley Rats. J Anim physial A Anim Nutr. 1997;77:61–5.CrossRef Farriol M, Rosello J, Schwarz S. Body surface area in sprague—Dowley Rats. J Anim physial A Anim Nutr. 1997;77:61–5.CrossRef
17.
Zurück zum Zitat Abramov Y, Golden B, Sullivan M, Botros SM, Miller J-JR, Alshahrour A, Goldberg RP, Sand PK. Histologic characterization of vaginal vs. abdominal surgical wound healing in rabbit model. Wound Rep Reg. 2007;15:80–6.CrossRef Abramov Y, Golden B, Sullivan M, Botros SM, Miller J-JR, Alshahrour A, Goldberg RP, Sand PK. Histologic characterization of vaginal vs. abdominal surgical wound healing in rabbit model. Wound Rep Reg. 2007;15:80–6.CrossRef
18.
Zurück zum Zitat Murray CJL, Lopez AD editors. The global burden of disease: a comprehensive assessment of mortality an disability from diseases, injuries and risk factors in 1990 and projected to 2020, vol 1. Boston, MA, USA: World Health Organization; 1996. Murray CJL, Lopez AD editors. The global burden of disease: a comprehensive assessment of mortality an disability from diseases, injuries and risk factors in 1990 and projected to 2020, vol 1. Boston, MA, USA: World Health Organization; 1996.
19.
Zurück zum Zitat Yılmaz S, Sezer RE, Karagöz N, Erçöçen AR, Sezer H, et al. Sivas’ta alan taramasıyla yanık insidansının araştırılması. Türkiye Klinikleri. J Med Sci. 2010;30(5):1552–60. Yılmaz S, Sezer RE, Karagöz N, Erçöçen AR, Sezer H, et al. Sivas’ta alan taramasıyla yanık insidansının araştırılması. Türkiye Klinikleri. J Med Sci. 2010;30(5):1552–60.
20.
Zurück zum Zitat Avşaroğulları L, Sözüer E, İkizceli İ, Kekeç Z, Yürümez Y, Özkan S. Adult burn injuries in an emergency department in central Anatolia, Turkey: a 5-year analysis. Burn. 2003;29:571–7.CrossRef Avşaroğulları L, Sözüer E, İkizceli İ, Kekeç Z, Yürümez Y, Özkan S. Adult burn injuries in an emergency department in central Anatolia, Turkey: a 5-year analysis. Burn. 2003;29:571–7.CrossRef
21.
Zurück zum Zitat Salmanpakoğlu N. Yanıklar ve Tedavileri. GATA Basımevi Ankara; 1998. s. 11. Salmanpakoğlu N. Yanıklar ve Tedavileri. GATA Basımevi Ankara; 1998. s. 11.
23.
Zurück zum Zitat Pistor M. What is mesotherapy? Chir dest Fr. 1976;46(288):59–60. Pistor M. What is mesotherapy? Chir dest Fr. 1976;46(288):59–60.
24.
Zurück zum Zitat Rotunda AM, Kolodney MS. Mesotherapy and phosplasticdylcholtne injections: historical claritication and review. Dermatol Surg. 2006;32(4):465–80.PubMed Rotunda AM, Kolodney MS. Mesotherapy and phosplasticdylcholtne injections: historical claritication and review. Dermatol Surg. 2006;32(4):465–80.PubMed
25.
Zurück zum Zitat Meskes CJ, Laoussadi S, Kac-Ohana N, Laseire O. Contralled trial of injektable diclotenal in mesotherapy fort he treatment of tendinitis. Rev Rhum Mal osteoartic. 1990;57(7):589–91. Meskes CJ, Laoussadi S, Kac-Ohana N, Laseire O. Contralled trial of injektable diclotenal in mesotherapy fort he treatment of tendinitis. Rev Rhum Mal osteoartic. 1990;57(7):589–91.
26.
Zurück zum Zitat Aurust SD, Thomas CE, Morehouse LA, Saito M, Bucher JR. Active oxygen and toxicity. Adv Exp Med Biol. 1986;197:513–26.CrossRef Aurust SD, Thomas CE, Morehouse LA, Saito M, Bucher JR. Active oxygen and toxicity. Adv Exp Med Biol. 1986;197:513–26.CrossRef
27.
Zurück zum Zitat Şener G, Şehirli AO, Şatıroğlu H, Keyer-Uysal M, Yeğen C. Melatonin improves oxidative organ damage in a rat model of thermal injury. Burns. 2002;28:419–25.CrossRefPubMed Şener G, Şehirli AO, Şatıroğlu H, Keyer-Uysal M, Yeğen C. Melatonin improves oxidative organ damage in a rat model of thermal injury. Burns. 2002;28:419–25.CrossRefPubMed
28.
Zurück zum Zitat Şehirli AO, Şener G, Şatıroğlu H, Ayanoğlu-Dülger G. Protective effect of N-acetylcysteine on renal ischemia/reperfüsyon injury in rat. J Nephrol. 2003;16:75–8.PubMed Şehirli AO, Şener G, Şatıroğlu H, Ayanoğlu-Dülger G. Protective effect of N-acetylcysteine on renal ischemia/reperfüsyon injury in rat. J Nephrol. 2003;16:75–8.PubMed
29.
30.
Zurück zum Zitat Youn YK, Suh GJ, Jung SE, Oh SK, Demling R. Recombinant human growth hormone decreases lung and liver tissue lipid peroxidation and increases antioxsidant activity after thermal injury in rats. J Burn Care Rehabil. 1998;19:548.CrossRef Youn YK, Suh GJ, Jung SE, Oh SK, Demling R. Recombinant human growth hormone decreases lung and liver tissue lipid peroxidation and increases antioxsidant activity after thermal injury in rats. J Burn Care Rehabil. 1998;19:548.CrossRef
31.
Zurück zum Zitat Youn YK, LaLonde C, Demling R. Oxidant and the pathophysiology of burn and smoke inhalation injury. Free Radic Biol Med. 1992;12:409–15.CrossRefPubMed Youn YK, LaLonde C, Demling R. Oxidant and the pathophysiology of burn and smoke inhalation injury. Free Radic Biol Med. 1992;12:409–15.CrossRefPubMed
32.
Zurück zum Zitat Nguyen TT, Cox CS, Traber DL, Gasser H, Redl H, Schlag G, et al. Free radical activity and loss of plasma antioxidants, vitamin E and sulfhydryl groups in patients with burns: the 1993 Moyer Award. J Burn Care Rehabil. 1993;14:602–9.CrossRefPubMed Nguyen TT, Cox CS, Traber DL, Gasser H, Redl H, Schlag G, et al. Free radical activity and loss of plasma antioxidants, vitamin E and sulfhydryl groups in patients with burns: the 1993 Moyer Award. J Burn Care Rehabil. 1993;14:602–9.CrossRefPubMed
33.
Zurück zum Zitat LaLonde C, Nayak U, Hennigan J, Demling RH. Excessive liver oxidant stress causes mortality in response to burn injury combined with endotoxin and is prevented with antioxidants. J Burn Care Rehabil. 1997;18:187–92.CrossRefPubMed LaLonde C, Nayak U, Hennigan J, Demling RH. Excessive liver oxidant stress causes mortality in response to burn injury combined with endotoxin and is prevented with antioxidants. J Burn Care Rehabil. 1997;18:187–92.CrossRefPubMed
34.
Zurück zum Zitat Parihar A, Parihar MS, Milner S, Bhat S. Oxidative stres and antioxidative mobilization in burn injury. Burns. 2008;34:6–17.CrossRefPubMed Parihar A, Parihar MS, Milner S, Bhat S. Oxidative stres and antioxidative mobilization in burn injury. Burns. 2008;34:6–17.CrossRefPubMed
35.
Zurück zum Zitat Militante J, Lombardini JB. Age related retinal degeneration in animal models of aging: possible involuement of tourine deficiency and oxidative stress. Neurochem Res. 1996;29(1):84–6. Militante J, Lombardini JB. Age related retinal degeneration in animal models of aging: possible involuement of tourine deficiency and oxidative stress. Neurochem Res. 1996;29(1):84–6.
36.
Zurück zum Zitat Militante JD, Lombardini JB. Treatment of hypertension with oral tourine: experimental and clinical studies. Amino Acids. 2002;23(4):381–93.CrossRefPubMed Militante JD, Lombardini JB. Treatment of hypertension with oral tourine: experimental and clinical studies. Amino Acids. 2002;23(4):381–93.CrossRefPubMed
37.
Zurück zum Zitat Knoll B. Bildatlas der ästhetischen Mesotherapie wirkstoffe/dosierung/Anwendung. Berlin: KVM; 2010. p. 3–4. Knoll B. Bildatlas der ästhetischen Mesotherapie wirkstoffe/dosierung/Anwendung. Berlin: KVM; 2010. p. 3–4.
38.
Zurück zum Zitat Kargı E, Deren O, Babucçu O, Hoşnuter M, Erdoğan B. Dual synergistic effect: the effect of dexamethasone plus carnitine on skin flap survival. Ann Plast Surg. 2004;53:488–91.CrossRefPubMed Kargı E, Deren O, Babucçu O, Hoşnuter M, Erdoğan B. Dual synergistic effect: the effect of dexamethasone plus carnitine on skin flap survival. Ann Plast Surg. 2004;53:488–91.CrossRefPubMed
39.
Zurück zum Zitat Deveci M, Öztürk S, Bayram Y, Aydın A, Eken A, Şengezer M. Diyabetik yaraların tedavisinde topikal glutatyon uygulaması. Turk Plast Surg. 2005;13(3):179–84. Deveci M, Öztürk S, Bayram Y, Aydın A, Eken A, Şengezer M. Diyabetik yaraların tedavisinde topikal glutatyon uygulaması. Turk Plast Surg. 2005;13(3):179–84.
40.
Zurück zum Zitat Vaalamo M, Leivo T, Saarialho-Kere U. Differential expression of tissueinhibitors of metalloproteinases (TIMP-1, -2, -3, and -4) in normal and aberrant wound healing. Hum Pathol. 1999;30:795–802.CrossRefPubMed Vaalamo M, Leivo T, Saarialho-Kere U. Differential expression of tissueinhibitors of metalloproteinases (TIMP-1, -2, -3, and -4) in normal and aberrant wound healing. Hum Pathol. 1999;30:795–802.CrossRefPubMed
41.
Zurück zum Zitat Vaalamo M, Mattila L, Iohansson N, et al. Distinct populations of stromal cells express collagenase-3 (MMP-13) and collagenase-1 (MMP-1) in chronic ulcers but not in normally healing wounds. J Invest Dermatol. 1997;109:96–101.CrossRefPubMed Vaalamo M, Mattila L, Iohansson N, et al. Distinct populations of stromal cells express collagenase-3 (MMP-13) and collagenase-1 (MMP-1) in chronic ulcers but not in normally healing wounds. J Invest Dermatol. 1997;109:96–101.CrossRefPubMed
42.
Zurück zum Zitat Grinell F, Zhu M. Fibronectin degradation in chronic wounds dependson the relative levels of elastase, alpha1-proteinase inhibitor, and alpha2-macroglobulin. J Invest Dermatol. 1996;106:335–41.CrossRef Grinell F, Zhu M. Fibronectin degradation in chronic wounds dependson the relative levels of elastase, alpha1-proteinase inhibitor, and alpha2-macroglobulin. J Invest Dermatol. 1996;106:335–41.CrossRef
43.
Zurück zum Zitat Shandall AA, Williams GT, Hallet MB, et al. Colonic healing: a role for polymorphonuclear leucocytes and oxygen radical production. Br J Surg. 1986;73:225–8.CrossRefPubMed Shandall AA, Williams GT, Hallet MB, et al. Colonic healing: a role for polymorphonuclear leucocytes and oxygen radical production. Br J Surg. 1986;73:225–8.CrossRefPubMed
44.
Zurück zum Zitat Mallya SK, Mookhtiar KA, Gao Y, et al. Characterization of 58-kilodalton human neutrophil collagenase: comparison with human fibroblast collagenase. Biochemistry. 1990;29:10628–34.CrossRefPubMed Mallya SK, Mookhtiar KA, Gao Y, et al. Characterization of 58-kilodalton human neutrophil collagenase: comparison with human fibroblast collagenase. Biochemistry. 1990;29:10628–34.CrossRefPubMed
45.
Zurück zum Zitat Punch J, Rees RS, Cashmer B, et al. Xanthine oxidase: its role in no-reflow phenomenon. Surgery. 1992;111:169–76.PubMed Punch J, Rees RS, Cashmer B, et al. Xanthine oxidase: its role in no-reflow phenomenon. Surgery. 1992;111:169–76.PubMed
46.
Zurück zum Zitat Wilkens EW, Rees R, Smith D, et al. Identification of xanthine oxidase activity following reperfusion in human tissue. Ann Plast Surg. 1993;31:60–5.CrossRef Wilkens EW, Rees R, Smith D, et al. Identification of xanthine oxidase activity following reperfusion in human tissue. Ann Plast Surg. 1993;31:60–5.CrossRef
47.
Zurück zum Zitat Upadhya GA, Strasberg SM. Glutathione, lactobionate, and histidine: cryptic inhibitors of matrix metalloproteinases contained in University of Wisconsin and histidine/tryptophan/ketoglutarate liver preservation solutions. Hepatology. 2000;31:1115–22.CrossRefPubMed Upadhya GA, Strasberg SM. Glutathione, lactobionate, and histidine: cryptic inhibitors of matrix metalloproteinases contained in University of Wisconsin and histidine/tryptophan/ketoglutarate liver preservation solutions. Hepatology. 2000;31:1115–22.CrossRefPubMed
48.
Zurück zum Zitat Kopal C, Deveci M, Ozturk S, Sengezer M. Effects of topical glutathione treatment in rat ischemic wound model. Ann Plast Surg. 2007;58(4):449–55.CrossRefPubMed Kopal C, Deveci M, Ozturk S, Sengezer M. Effects of topical glutathione treatment in rat ischemic wound model. Ann Plast Surg. 2007;58(4):449–55.CrossRefPubMed
49.
Zurück zum Zitat Tintinalli JE. Emergency Medicine. A Comprehensive Study Guide (Emergency Medicine (Tintinalli)). New York: McGraw-Hill Companies; 2010. p. 1374–86. Tintinalli JE. Emergency Medicine. A Comprehensive Study Guide (Emergency Medicine (Tintinalli)). New York: McGraw-Hill Companies; 2010. p. 1374–86.
Metadaten
Titel
Efficacy of glutathione mesotherapy in burns: an experimental study
verfasst von
A. Buz
T. Görgülü
A. Olgun
E. Kargi
Publikationsdatum
27.11.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Trauma and Emergency Surgery / Ausgabe 6/2016
Print ISSN: 1863-9933
Elektronische ISSN: 1863-9941
DOI
https://doi.org/10.1007/s00068-015-0607-8

Weitere Artikel der Ausgabe 6/2016

European Journal of Trauma and Emergency Surgery 6/2016 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.